Prestige Consumer Healthcare Inc. 8-K

What Happened Prestige Consumer Healthcare Inc. (through its wholly owned subsidiary Prestige Brands, Inc.) announced on July 15, 2026 that Prestige Brands issued $400.0 million aggregate principal amount of 6.250% senior notes due July 15, 2034. Interest on the notes is payable semiannually on January 15 and July 15, beginning January 15, 2027. The notes are senior unsecured obligations of Prestige Brands and are guaranteed on an unsecured senior basis by the Company and certain domestic restricted subsidiaries. The 8-K was filed under Item 1.01 (material definitive agreement) and Item 2.03 (creation of a direct financial obligation).

Key Details

• Principal amount: $400.0 million; coupon: 6.250%; maturity date: July 15, 2034.
• Interest payments: January 15 and July 15 each year, first payment January 15, 2027.
• Redemption: callable on or after July 15, 2029 at specified prices; prior to that date may be redeemed at 100% plus a make-whole premium; up to 40% may be redeemed before July 15, 2029 with certain equity offering proceeds (subject to conditions).
• Other provisions: Change-of-control repurchase at 101% of principal; Indenture includes customary covenants and events of default that limit certain debt, dividend, lien, asset sale, merger and affiliate transaction activities (with exceptions). Notes were sold privately to qualified institutional buyers under Rule 144A and to non-U.S. persons under Regulation S.

Why It Matters This transaction creates a long-term, fixed-rate debt obligation that will affect the company’s capital structure, interest expense and liquidity profile through 2034. The notes are unsecured but senior, and the accompanying covenants may limit Prestige’s ability to take on additional debt or make certain corporate actions without meeting conditions in the Indenture. Investors should note the amount, coupon and maturities when assessing Prestige’s leverage, future interest costs and potential impacts on cash flow and capital allocation. The full Indenture and form of note are filed as exhibits to the 8-K for detailed terms.